On February 22, NKCL Bio Group held a ceremony for
the completion of the automatic cell culture system at the Grand Hyatt Seoul
Grand Ballroom. NKCL Bio Group, which set a platform for the popularization of
NK immune cells, announced plans to accelerate the business by the completion of
an automated culture system that combines artificial intelligence and cell
culture technology.
NKCL Bio Group is a company specializing in
'personalized immune care' that researches and develops NK immune cell therapy with
patents and original technology for a medium addition kit and culture method
for NK cell culture. NK immune cells, also called natural killer cells, are
immune cells in the body with the ability to kill abnormal cells, and are
effective in eliminating cancer cells and anti-aging.
NKCL Bio
Group introduces a variety of product lineup such as bottled water, dry food,
and cosmetics and plans to launch various product groups in the future.
Shin
Dong-hwa, chairman of NKCL Bio Group, said, “Among
the various product lines, our cosmetics containing NK cell culture medium not
only regenerate, but also have anti-inflammatory and antibacterial functions,
which helps the elderly to regenerate skin and improve troubles, also is effective
for atopy and psoriasis. In addition, NK Cordycep Gold 300 is cordycepin
cultured from rice as a host. The content of cordycepin is 5 to 10 times higher
than that of wild cordyceps, which is difficult to cultivate. Cordycepin, a
core raw material, acts as an anticancer agent, so it plays an auxiliary role
in cancer treatment, helps prevent cancer recurrence, and is effective in
improving diseases such as diabetes and blood pressure.”
NKCL Bio
Group's strength lies in its automated culture system that incorporates
artificial intelligence (AI).
Existing
NK cell culture has relied on specialized researchers for the entire process.
With this method, it is difficult to secure scarce, high-quality manpower, and
the number of culture cases that can be managed per researcher is limited to a
maximum of 3 people per day, so there is a limitation to productivity. On the
other hand, the GMP automatic culture system with artificial intelligence finds
the optimal culture environment for NK cell culture and enables culture up to
300 people per day. In other words, it can be 100 times more efficient than
before.
NKCL Bio
Group Chairman Shin Dong-hwa said, “In the automatic cell
culture system, expert data and know-how are combined with artificial
intelligence, so that the optimal culture environment for each individual can
be determined by AI. In addition, it has the advantage of being able to block
concerns about human error and technology leakage.” “By
introducing an automatic cell culture system, labor and production costs can be
greatly reduced, thereby reducing the cost of treatment, realizing mass
production and popularization of NK cell therapy.”
NKCL's
automated culture system consists of a GMP certified culture line, a controlled
environment change line, a transport line, and a packaging line, etc. The
entire line is to be managed through the Manufacturing Execution System (MES),
and all production history (production management, history management, tracking
management system) and patient biodata are recorded and safely stored and
distributed by block chain technology.
Meanwhile,
NKCL Bio Group, which has been providing personalized immune checkup and
treatment programs, plans to establish an NK immune therapy center in
cooperation with hospitals nationwide, including Dongtan, Busan, Yangsan, and
Gwangju, in the first half of this year. To this end, it is establishing a
diagnosis and treatment system by sharing programs on immunotherapy in
collaboration with major domestic hospitals.
The NK
Immune Therapy Center will consist of a comprehensive medical flex mall, an
immune checkup center, an immunotherapy center, an immune drug store, and an
immune cafe.
In
addition, NKCL Bio Group plans to enter the CDMO market as it has built an
automatic culture system. At the same time, the company plans to expand its
product lineup while spurring overseas expansion such as China and Malaysia.
Shin
Dong-hwa, Chairman of NKCL Bio Group, said, “We are
developing a product line to improve immunity and treat diseases. But more
important than treatment is prevention. In particular, as the average lifespan
of modern people is increasing and the age of 100 years old approaching,
immunity is important to live a healthier and more energetic life in old age. and
it has to be managed continuously from a young age,” he
said.
"Our
goal is to contribute to helping many people lead a long and healthy life, by
focusing on supplementing and enhancing people's immunity," he added.
URL1. http://kangso.co.kr/View.aspx?No=2241378
URL2. http://www.mdjournal.kr/news/articleView.html?idxno=35025